Literature DB >> 24680271

[An improved protocol for primary culture of cardiomyocyte from neonatal rat].

Jing Tao1, Yitong Ma2, Xiaomei Li, Bangdang Chen, Yining Yang, Xiang Ma, Fen Liu, Xiaocui Chen, Mintao Gai.   

Abstract

OBJECTIVE: The present study describes an improved in vitro culture method for obtaining high purity, vital and fully functional cardiomyocytes from neonatal rat.
METHODS: After cutting ventricular tissue with improved method, ventricular tissues were digested with low concentrations of trypsin overnight at 4 °C, and then underwent collagenase II digestion. Thereafter, cardiomyocytes were purified by combined differential adhesion and chemical inhibition methods.
RESULTS: Adherent cardiomyocytes were seen at 12 h after culture, spontaneously beating cardiomyocytes were observed at 24 h after culture, crosslinked cardiomyocytes were found at 48 h after culture, adhesion clustered cardiomyocytes were seen at 72 h after culture, dense network formed from inter-connected was evidenced together with radial arranged cell clusters and cell pseudopodia 96 h the mutual contact woven into and formed radically ordering cell clusters and island-like beating cardiomyocytes at 96 h after culture. The cell survival rate and purity were more than 98%.
CONCLUSION: Fully functional spontaneous beating cardiomyocytes can be obtained by the use of this improved primary neonatal rat cardiomyocytes culture method.

Entities:  

Mesh:

Year:  2014        PMID: 24680271

Source DB:  PubMed          Journal:  Zhonghua Xin Xue Guan Bing Za Zhi        ISSN: 0253-3758


  2 in total

1.  The Effects of Dracocephalum Heterophyllum Benth Flavonoid on Hypertrophic Cardiomyocytes Induced by Angiotensin II in Rats.

Authors:  Hong Jiang; Chen Zhang; Wen He
Journal:  Med Sci Monit       Date:  2018-09-10

2.  Oridonin Relieves Angiotensin II-Induced Cardiac Remodeling via Inhibiting GSDMD-Mediated Inflammation.

Authors:  Shuang Lin; Shanshan Dai; Jiahui Lin; Xiaohe Liang; Weiqi Wang; Weijian Huang; Bozhi Ye; Xia Hong
Journal:  Cardiovasc Ther       Date:  2022-03-14       Impact factor: 3.023

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.